BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 19137602)

  • 1. Granulocyte-monocyte adsorptive apheresis in pediatric inflammatory bowel disease: results, practical issues, safety, and future perspectives.
    Ruuska T; Wewer V; Lindgren F; Malmborg P; Lindquist M; Marthinsen L; Browaldh L; Casswall T; Kalliomäki M; Grönlund J
    Inflamm Bowel Dis; 2009 Jul; 15(7):1049-54. PubMed ID: 19137602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort study.
    Motoya S; Tanaka H; Shibuya T; Osada T; Yamamoto T; Hongo H; Mizuno C; Saito D; Aoyama N; Kobayashi T; Ito H; Tanida S; Nojima M; Kokuma S; Hosoi E
    BMC Gastroenterol; 2019 Nov; 19(1):196. PubMed ID: 31752695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
    Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of granulocyte, monocyte/macrophage adsorptive in pediatric ulcerative colitis.
    Ruuska T; Küster P; Grahnquist L; Lindgren F; Wewer AV
    World J Gastroenterol; 2016 May; 22(17):4389-96. PubMed ID: 27158208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with the outcomes in ulcerative colitis patients undergoing granulocyte and monocyte adsorptive apheresis as remission induction therapy: A multicenter cohort study.
    Ishiguro Y; Ohmori T; Umemura K; Iizuka M
    Ther Apher Dial; 2021 Aug; 25(4):502-512. PubMed ID: 33029920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective Single Center Study of Granulocyte Monocyte Adsorption Apheresis Treatment in Inflammatory Bowel Disease.
    Edfors K; Ståhlberg D; Söderman C
    Ther Apher Dial; 2016 Feb; 20(1):79-85. PubMed ID: 26841133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Usefulness of New Single-Needle Intensive Granulocyte and Monocyte Adsorptive Apheresis in Active Ulcerative Colitis Patients Without Corticosteroids and Biologics.
    Shimazu K; Fukuchi T; Kim I; Noguchi Y; Iwata M; Koyama S; Ubukata S; Tanaka A
    Ther Apher Dial; 2016 Aug; 20(4):383-9. PubMed ID: 27523079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocytapheresis in steroid-dependent and steroid-resistant patients with inflammatory bowel disease: a prospective observational study.
    Sacco R; Romano A; Mazzoni A; Bertini M; Federici G; Metrangolo S; Parisi G; Nencini C; Giampietro C; Bertoni M; Tumino E; Scatena F; Bresci G
    J Crohns Colitis; 2013 Dec; 7(12):e692-7. PubMed ID: 23870727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis.
    Hanai H; Watanabe F; Yamada M; Sato Y; Takeuchi K; Iida T; Tozawa K; Tanaka T; Maruyama Y; Matsushita I; Iwaoka Y; Kikuch K; Saniabadi AR
    Digestion; 2004; 70(1):36-44. PubMed ID: 15297776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting neutrophils in inflammatory bowel disease: revisiting the role of adsorptive granulocyte and monocyte apheresis.
    Bamias G; Zampeli E; Domènech E
    Expert Rev Gastroenterol Hepatol; 2022 Aug; 16(8):721-735. PubMed ID: 35833363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of children and adolescents with ulcerative colitis by adsorptive depletion of myeloid lineage leucocytes as monotherapy or in combination with low dose prednisolone after failure of first-line medications.
    Tanaka T; Sugiyama S; Goishi H; Kajihara T; Akagi M; Miura T
    BMC Gastroenterol; 2013 Aug; 13():130. PubMed ID: 23961883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ulcerative colitis with hepatitis B virus infection treated successfully by granulocyte monocyte apheresis.
    Saito H; Hanafusa N; Kishikawa J; Noiri E; Sunami E; Ishihara S; Watanabe T; Nangaku M
    J Clin Apher; 2016 Dec; 31(6):584-586. PubMed ID: 26876484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte and Monocyte Apheresis for Induction of Remission in Children With New-Onset Inflammatory Bowel Colitis.
    Rolandsdotter H; Eberhardson M; Fagerberg UL; Finkel Y
    J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):84-89. PubMed ID: 28604509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.
    Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K
    Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of refractory Crohn's disease by intensive granulocyte and monocyte adsorption apheresis: a report on two drug refractory cases.
    Kato S; Kani K; Takabayashi H; Yamamoto R; Ogawa T; Matsuda A; Yakabi K
    Intern Med; 2011; 50(15):1591-3. PubMed ID: 21804287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants.
    Yoshino T; Nakase H; Matsuura M; Matsumura K; Honzawa Y; Fukuchi T; Watanabe K; Murano M; Tsujikawa T; Fukunaga K; Matsumoto T; Chiba T
    Digestion; 2011; 84(1):3-9. PubMed ID: 21311190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Granulocyte and Monocyte Adsorptive Apheresis in Patients With Inflammatory Bowel Disease Showing Lost Response to Infliximab.
    Yokoyama Y; Sawada K; Aoyama N; Yoshimura N; Sako M; Hirai F; Kashiwagi N; Suzuki Y
    J Crohns Colitis; 2020 Sep; 14(9):1264-1273. PubMed ID: 32166331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease.
    Lindberg A; Eberhardson M; Karlsson M; Karlén P
    BMC Gastroenterol; 2010 Jul; 10():73. PubMed ID: 20604939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.
    Saniabadi AR; Tanaka T; Ohmori T; Sawada K; Yamamoto T; Hanai H
    World J Gastroenterol; 2014 Aug; 20(29):9699-715. PubMed ID: 25110409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyoderma gangrenosum in an ulcerative colitis patient during treatment with vedolizumab responded favorably to adsorptive granulocyte and monocyte apheresis.
    Shibuya T; Haga K; Saeki M; Haraikawa M; Tsuchihashi H; Okahara K; Nomura O; Fukushima H; Murakami T; Ishikawa D; Ikeda S; Nagahara A
    J Clin Apher; 2020 Sep; 35(5):488-492. PubMed ID: 32767842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.